Literature DB >> 11895968

Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.

Feng Qian1, Weiqing Pan.   

Abstract

Attenuated Salmonella strains are an attractive live vector for delivery of a foreign antigen to the human immune system. However, the problem with this vector lies with plasmid segregation and the low level of expression of the foreign gene in vivo when constitutive expression is employed, leading to a diminished immune response. We have established inducible expressions of foreign genes in the Salmonella enterica serovar Typhi CVD908 vaccine strain using the tetracycline response regulatory promoter. To set up this system, a tetracycline repressor (tetR) was integrated into a defined Delta aroC locus of the chromosome via suicide plasmid pJG12/tetR-neo. To remove the neo gene conferring kanamycin resistance from the locus, a cre expression vector under the control of the tetracycline response promoter was transformed into the clone; expression of the Cre recombinase excised the neo gene and generated the end strain CVD908-tetR. Expression of the luciferase reporter gene in this strain is dependent on the presence of tetracycline in the medium and can be regulated up to 4,773-fold. Moreover, the tightly controlled expression of major merozoite surface protein 1 (MSP1) and parts of Plasmodium falciparum was achieved, and the product yield was increased when the inducible expression system was employed. Inoculation of bacteria harboring plasmid pZE11/MSP1(42) in mice produced the protein in liver and spleen controlled by the inducer. The persistence of the plasmid-carrying bacteria in mice was determined. Peak colonization of both liver and spleen was detected on the third day postinoculation and was followed by a decline in growth curves. After 14 days postinfection, the majority of the bacteria (>90%) recovered from the liver and spleen of the mice retained the plasmid when expression was induced; this clearly indicated that stability of the expression vector in vivo was improved by inducible expression. Establishment of the regulatory system in the vaccine strain may broaden the range of its use by enhancing plasmid stability and expression levels in vivo. Moreover, the availability of the vaccine strain inducibly expressing the entire MSP1 provides possibilities for examining its immunogenicity, particularly the cellular response in animal models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895968      PMCID: PMC127878          DOI: 10.1128/IAI.70.4.2029-2038.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.

Authors:  J E Galen; J Nair; J Y Wang; S S Wasserman; M K Tanner; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

Authors:  J E Galen; O G Gomez-Duarte; G A Losonsky; J L Halpern; C S Lauderbaugh; S Kaintuck; M K Reymann; M M Levine
Journal:  Vaccine       Date:  1997 Apr-May       Impact factor: 3.641

Review 3.  Live attenuated Salmonella: a paradigm of mucosal vaccines.

Authors:  J C Sirard; F Niedergang; J P Kraehenbuhl
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

4.  Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains.

Authors:  R A Strugnell; D Maskell; N Fairweather; D Pickard; A Cockayne; C Penn; G Dougan
Journal:  Gene       Date:  1990-03-30       Impact factor: 3.688

5.  Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.

Authors:  C R González; F R Noriega; S Huerta; A Santiago; M Vega; J Paniagua; V Ortiz-Navarrete; A Isibasi; M M Levine
Journal:  Vaccine       Date:  1998 May-Jun       Impact factor: 3.641

6.  Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria.

Authors:  R Hall; J E Hyde; M Goman; D L Simmons; I A Hope; M Mackay; J Scaife; B Merkli; R Richle; J Stocker
Journal:  Nature       Date:  1984 Sep 27-Oct 3       Impact factor: 49.962

7.  Merozoite surface antigen-I of plasmodium.

Authors:  J A Cooper
Journal:  Parasitol Today       Date:  1993-02

8.  Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

Authors:  J C Sadoff; W R Ballou; L S Baron; W R Majarian; R N Brey; W T Hockmeyer; J F Young; S J Cryz; J Ou; G H Lowell
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

9.  Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells.

Authors:  A Aggarwal; S Kumar; R Jaffe; D Hone; M Gross; J Sadoff
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA.

Authors:  D C Lowe; T C Savidge; D Pickard; L Eckmann; M F Kagnoff; G Dougan; S N Chatfield
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  7 in total

1.  Tight modulation of Escherichia coli bacterial biofilm formation through controlled expression of adhesion factors.

Authors:  Sandra Da Re; Benjamin Le Quéré; Jean-Marc Ghigo; Christophe Beloin
Journal:  Appl Environ Microbiol       Date:  2007-03-23       Impact factor: 4.792

2.  Tetracycline-dependent conditional gene knockout in Bacillus subtilis.

Authors:  Annette Kamionka; Ralph Bertram; Wolfgang Hillen
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

3.  Borrelia burgdorferi ftsZ plays a role in cell division.

Authors:  Lydia Dubytska; Henry P Godfrey; Felipe C Cabello
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

4.  A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells.

Authors:  Valeria Gonzalez-Nicolini; Cornelia Fux; Martin Fussenegger
Journal:  Invest New Drugs       Date:  2004-08       Impact factor: 3.850

5.  Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.

Authors:  Sabine Ehrt; Xinzheng V Guo; Christopher M Hickey; Marvin Ryou; Mercedes Monteleone; Lee W Riley; Dirk Schnappinger
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

Review 6.  The application of Tet repressor in prokaryotic gene regulation and expression.

Authors:  Ralph Bertram; Wolfgang Hillen
Journal:  Microb Biotechnol       Date:  2008-01       Impact factor: 5.813

Review 7.  Status quo of tet regulation in bacteria.

Authors:  Ralph Bertram; Bernd Neumann; Christopher F Schuster
Journal:  Microb Biotechnol       Date:  2021-10-29       Impact factor: 5.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.